Star Equity (STRR) Competitors $1.95 0.00 (0.00%) As of 07/3/2025 01:36 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock STRR vs. BDMD, FEMY, VVOS, PETV, RVP, NXGL, ALUR, CLGN, NRXS, and PSTVShould you be buying Star Equity stock or one of its competitors? The main competitors of Star Equity include Baird Medical Investment (BDMD), Femasys (FEMY), Vivos Therapeutics (VVOS), PetVivo (PETV), Retractable Technologies (RVP), NexGel (NXGL), Allurion Technologies (ALUR), CollPlant Biotechnologies (CLGN), NeurAxis (NRXS), and Plus Therapeutics (PSTV). These companies are all part of the "medical equipment" industry. Star Equity vs. Its Competitors Baird Medical Investment Femasys Vivos Therapeutics PetVivo Retractable Technologies NexGel Allurion Technologies CollPlant Biotechnologies NeurAxis Plus Therapeutics Star Equity (NASDAQ:STRR) and Baird Medical Investment (NASDAQ:BDMD) are both small-cap medical equipment companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, dividends, institutional ownership, analyst recommendations, earnings and profitability. Does the media favor STRR or BDMD? In the previous week, Baird Medical Investment had 1 more articles in the media than Star Equity. MarketBeat recorded 1 mentions for Baird Medical Investment and 0 mentions for Star Equity. Star Equity's average media sentiment score of 0.00 beat Baird Medical Investment's score of -0.63 indicating that Star Equity is being referred to more favorably in the media. Company Overall Sentiment Star Equity Neutral Baird Medical Investment Negative Do analysts recommend STRR or BDMD? Star Equity presently has a consensus price target of $5.00, suggesting a potential upside of 156.41%. Given Star Equity's stronger consensus rating and higher possible upside, analysts clearly believe Star Equity is more favorable than Baird Medical Investment.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Star Equity 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Baird Medical Investment 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has preferable earnings and valuation, STRR or BDMD? Baird Medical Investment has lower revenue, but higher earnings than Star Equity. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioStar Equity$57.17M0.11-$10.44M-$3.43-0.57Baird Medical Investment$37.04M0.70N/AN/AN/A Is STRR or BDMD more profitable? Baird Medical Investment has a net margin of 0.00% compared to Star Equity's net margin of -16.43%. Baird Medical Investment's return on equity of 0.00% beat Star Equity's return on equity.Company Net Margins Return on Equity Return on Assets Star Equity-16.43% -8.24% -3.48% Baird Medical Investment N/A N/A N/A Which has more volatility and risk, STRR or BDMD? Star Equity has a beta of 0.93, indicating that its share price is 7% less volatile than the S&P 500. Comparatively, Baird Medical Investment has a beta of -0.94, indicating that its share price is 194% less volatile than the S&P 500. Do insiders and institutionals have more ownership in STRR or BDMD? 3.8% of Star Equity shares are owned by institutional investors. Comparatively, 19.8% of Baird Medical Investment shares are owned by institutional investors. 33.5% of Star Equity shares are owned by insiders. Comparatively, 78.9% of Baird Medical Investment shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. SummaryBaird Medical Investment beats Star Equity on 7 of the 13 factors compared between the two stocks. Get Star Equity News Delivered to You Automatically Sign up to receive the latest news and ratings for STRR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding STRR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart STRR vs. The Competition Export to ExcelMetricStar EquityDIVERSIFIED OPS IndustryMulti-Sector SectorNASDAQ ExchangeMarket Cap$6.26M$15.98B$14.68B$8.95BDividend YieldN/A4.39%4.13%4.09%P/E Ratio-0.578.637.3620.24Price / Sales0.114.283.58125.07Price / Cash5.9833.0931.7957.47Price / Book0.182.362.085.67Net Income-$10.44M$951.45M$922.22M$248.47M7 Day Performance-3.47%3.46%3.10%3.29%1 Month Performance-14.85%0.86%0.05%5.18%1 Year Performance-50.88%-6.18%-4.67%21.35% Star Equity Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)STRRStar Equity3.6064 of 5 stars$1.95flat$5.00+156.4%-50.9%$6.26M$57.17M-0.57460Gap DownBDMDBaird Medical InvestmentN/A$3.66-6.2%N/AN/A$25.68MN/A0.00N/AGap UpHigh Trading VolumeFEMYFemasys3.7089 of 5 stars$0.97-1.4%$8.67+797.4%-15.1%$25.04M$1.63M-1.0630VVOSVivos Therapeutics1.3986 of 5 stars$3.16-3.7%$4.82+52.4%+75.9%$19.32M$15.03M-1.83160PETVPetVivoN/A$0.80+1.3%N/A+65.3%$19.17M$1.05M-1.7820High Trading VolumeRVPRetractable Technologies2.1244 of 5 stars$0.64+3.1%N/A-43.9%$18.56M$33.75M-1.18240Gap DownNXGLNexGel0.4472 of 5 stars$2.58+7.5%N/A+21.5%$18.37M$8.69M-5.7310Positive NewsALURAllurion Technologies2.8864 of 5 stars$2.46+1.2%$22.83+828.2%-92.0%$18.12M$32.11M-0.20501CLGNCollPlant Biotechnologies2.5315 of 5 stars$1.36-1.4%$11.50+745.6%-72.3%$17.55M$2.47M-1.1170Gap DownNRXSNeurAxis3.514 of 5 stars$2.42-2.4%$7.00+189.3%-10.5%$17.46M$2.93M-1.3219Insider TradePSTVPlus Therapeutics1.7106 of 5 stars$0.35+10.4%$10.83+3,014.8%-80.7%$16.07MN/A-0.1220High Trading Volume Related Companies and Tools Related Companies Baird Medical Investment Competitors Femasys Competitors Vivos Therapeutics Competitors PetVivo Competitors Retractable Technologies Competitors NexGel Competitors Allurion Technologies Competitors CollPlant Biotechnologies Competitors NeurAxis Competitors Plus Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:STRR) was last updated on 7/4/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | Sponsored“E.I.”- The biggest prediction of my career?One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Star Equity Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Star Equity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free STRR Stock Alerts